NewsBenzingaCoya Therapeutics、2026年NEALS年次総会でポスター発表においてALSデータを紹介へ;同社は現在、ALS治療薬COYA 302の評価を目的とした第2/3相試験「ALSTARS試験」を実施中 Coya Therapeutics、2026年NEALS年次総会でポスター発表においてALSデータを紹介へ;同社は現在、ALS治療薬COYA 302の評価を目的とした第2/3相試験「ALSTARS試験」を実施中 Benzinga 2026.10.28 12:07 (GMT+0) Open on Benzinga Other news Binance Plans to Expand into Five Asian Markets Next Year, Focusing on South and Southeast Asia PancakeSwap rebrands as Pancake, CAKE token and contracts unchanged Top Wall Street Forecasters Revamp TJX Expectations Ahead Of Q3 Earnings Trump Reportedly Traded Over $97 Million Worth of Nvidia Stock in 2 Years — Elizabeth Warren Wants Congress to Force Him to ‘Divest’ A-Share Market Close: ChiNext Index Rebounds From Lows to Gain 0.85% as Shanghai-Shenzhen Turnover Hits New Low for the Year Nebius Shares Jump After Hours as Nvidia’s Strong Quarterly Numbers Lift AI Infrastructure Stocks
Trump Reportedly Traded Over $97 Million Worth of Nvidia Stock in 2 Years — Elizabeth Warren Wants Congress to Force Him to ‘Divest’
A-Share Market Close: ChiNext Index Rebounds From Lows to Gain 0.85% as Shanghai-Shenzhen Turnover Hits New Low for the Year